Health and Nutrition Status of Chinese Elderly

Completed

• Conditions: Malnutrition; Sarcopenia

• Registration Number: NCT02089906
• Lead Sponsor: Abbott Nutrition

Brief Summary

This study is aiming to understand the prevalence and risk factors related to malnutrition and sarcopenia in Chinese elderly.

Detailed Description

The study objective is to understand the prevalence of malnutrition and sarcopenia in Chinese elderly with the cut-off points from the normal range of muscle mass and function in Chinese adults; to understand the risk factors related to malnutrition and sarcopenia in Chinese elderly; to set up a screening tool on malnutrition and sarcopenia risks in Chinese elderly.

Study Timeline

• Study Start: 2014-03
• Study First Submitted: 2014-03-14
• Study First Submitted QC: 2014-03-17
• Study First Posted: 2014-03-18
• Primary Completion: 2015-07
• Study Completion: 2015-07
• Status Verified: 2015-08
• Last Update Submitted: 2015-08-03
• Last Update Posted: 2015-08-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2834

Inclusion Criteria

1. Male or female Chinese ages >= 60 years.
2. Subject lives in the community for more than 12 months.
3. Subject has voluntarily signed and dated an informed consent form, approved by an Independent Ethics Committee/Institutional Review Board (IEC/IRB) prior to any participation in the study.

Exclusion Criteria

1. Subject who did/does heavy manual labor
2. Subject who was a professional or semi-professional athlete or game player
3. Subject who has physical disabilities such as loss of hand or foot or limbs or any other physical disability which may affect the muscle mass by the opinion of the study physician.
4. Subject has an implanted electronic device or orthopedic metal implantations, such as pacemaker, cardiac defibrillator, subcutaneous injection pump, or metal hip, metal knee joint, metal fracture internal fixation, etc.
5. Subject who has active hyperthyroidism or hypothyroidism and needs medication treatment as by self-report.
6. Subject who has severe heart dysfunction or renal dysfunction with significant sodium water retention or edema by the opinion of study physicians.
7. Subject who takes hormones except for external application of glucocorticoids.
8. Subject who takes diuretics except for using a stable dose for at least 3 weeks as a part of hypertension treatment.
9. Subject who has later stage of malignancies with cachexia by the opinion of study physicians.
10. Subject has any other disease or situation who should not to participate in the study by the opinion of study physicians.
11. Subject had hand/wrist or foot/leg surgery/injury within the past 3 months and the surgery/injury may affect the hand grip or gait speed test by study physician's opinion.
12. Subject is too frail by study physician's opinion
13. Subject is drug addicted or alcohol addicted
14. Subject is participating in other clinical trials which are not approved by AN

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total skeletal muscle mass	Test Visit 1 (~ Day 7)	bioelectric impedance absorptiometry (BIA)

Secondary Outcome Measures

Name	Time	Method
Total body fat	Test Visit 1 (~Day 7) and Test Visit 2 (~ Day 17)
Total skeletal muscle mass	Test Visit 2 (~ Day 17)	Dual X-ray Absorptiometry (DXA)
Total body fat free mass	Test Visit 1 (~ Day 7) and Test Visit 2 (~ Day 17)
Hand grip strength	Test Visit 1 (~ Day 7)
Gait speed	Test Visit 1 (~ Day 7)

Trial Locations

Locations (3)

West China Hospital, Sichuan University; 🇨🇳 Chengdu, China

Peking Union Medical College Hospital; 🇨🇳 Beijing, China

Shanghai 6th People's Hospital; 🇨🇳 Shanghai, China